Genmab A (GNMSF) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $62.0 million.
- Genmab A's Receivables - Other rose 2653.06% to $62.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $62.0 million, marking a year-over-year increase of 2653.06%. This contributed to the annual value of $62.0 million for FY2025, which is 2653.06% up from last year.
- According to the latest figures from Q4 2025, Genmab A's Receivables - Other is $62.0 million, which was up 2653.06% from $49.0 million recorded in Q4 2024.
- In the past 5 years, Genmab A's Receivables - Other registered a high of $62.0 million during Q4 2025, and its lowest value of $43.0 million during Q4 2023.
- In the last 3 years, Genmab A's Receivables - Other had a median value of $49.0 million in 2024 and averaged $51.3 million.
- In the last 5 years, Genmab A's Receivables - Other skyrocketed by 1395.35% in 2024 and then surged by 2653.06% in 2025.
- Genmab A's Receivables - Other (Quarter) stood at $43.0 million in 2023, then increased by 13.95% to $49.0 million in 2024, then increased by 26.53% to $62.0 million in 2025.
- Its Receivables - Other was $62.0 million in Q4 2025, compared to $49.0 million in Q4 2024 and $43.0 million in Q4 2023.